WeVote

Bill

Bill

PS 1015

Para añadir los nuevos incisos (ee) y (ff) al Artículo 2; añadir un nuevo Artículo 10, y reenumerar los Artículos 10 al 25, como Artículos 11 al 26, de la Ley Núm. 70-1992, según enmendada, conocida como “Ley para la Reducción y el Reciclaje de Desperdicios Sólidos en Puerto Rico”, con el propósito de establecer el “Programa de Disposición de Medicamentos o Fármacos”, con o sin receta; y para otros fines relacionados.

2025-2028 Session

Puerto Rico establishes a mandatory pharmaceutical disposal program requiring safe collection and processing of prescription and over-the-counter medications to prevent environmental and public health contamination.

Referido a Comisión(es)
0
WeVote Research Nonpartisan
Bill Summary · PS 1015

Legislative bill overview

Bill PS 1015 amends Puerto Rico's solid waste reduction and recycling law (Law 70-1992) to establish a new "Medication and Pharmaceutical Disposal Program" for both prescription and over-the-counter drugs. The bill adds new definitions to Article 2 and creates an entirely new Article 10 dedicated to this program's framework and regulations.

Why is this important

Improper medication disposal poses serious environmental and public health risks—drugs entering water systems contaminate drinking water and harm aquatic ecosystems, while accessible discarded medications increase abuse potential. This legislation directly addresses a common public health blind spot by creating institutional mechanisms for safe pharmaceutical waste management across Puerto Rico.

Potential points of contention

  • Implementation costs and responsibility: Unclear whether costs fall on municipalities, pharmacies, healthcare facilities, or government—pharmaceutical industry involvement and cost-sharing mechanisms aren't detailed in the bill summary
  • Enforcement and monitoring: No specified penalties, compliance mechanisms, or oversight bodies mentioned; effectiveness depends heavily on implementation details not visible in this abstract
  • Pharmacy and healthcare provider burden: Mandatory participation by private pharmacies and clinics could create operational challenges and resistance without clear compensation or liability protections

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.